Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00252876




Registration number
NCT00252876
Ethics application status
Date submitted
10/11/2005
Date registered
15/11/2005
Date last updated
17/03/2008

Titles & IDs
Public title
GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
Scientific title
An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.
Secondary ID [1] 0 0
GALLEX 1
Secondary ID [2] 0 0
D6160C00038
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Type 2 Diabetes 0 0
Condition category
Condition code
Metabolic and Endocrine 0 0 0 0
Diabetes

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Adverse events, laboratory variables, physical examination, cardiac evaluation, hypoglycemic events, electrocardiogram, vital signs (blood pressure and pulse), body weight
Timepoint [1] 0 0
Secondary outcome [1] 0 0
Pharmacodynamic: fasting plasma glucose, glycosylated hemoglobin A1c, lipid variables (triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol)
Timepoint [1] 0 0
Secondary outcome [2] 0 0
Responder rates and proportion of patients on tesaglitazar who reach pre-specified target levels for triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol
Timepoint [2] 0 0
Secondary outcome [3] 0 0
C-reactive protein
Timepoint [3] 0 0
Secondary outcome [4] 0 0
Central obesity (waist circumference, hip circumference, waist/hip ratio)
Timepoint [4] 0 0

Eligibility
Key inclusion criteria
* Provision of a written informed consent
* Men or women who are >=18 years of age
* Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control
* Completed the last two visits of randomized treatment period in GALLANT 2/22, 5, 7, 8 or 14 studies.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Type 1 diabetes
* New York Heart Association heart failure Class III or IV
* Treatment with chronic insulin
* History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)
* History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)
* Creatinine levels above twice the normal range
* Creatine kinase above 3 times the upper limit of normal
* Previous enrollment in this long-term extension study
* Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/03/2005
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/01/2007
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Research Site - Adelaide
Recruitment hospital [2] 0 0
Research Site - Brisbane
Recruitment hospital [3] 0 0
Research Site - Cairns
Recruitment hospital [4] 0 0
Research Site - Geelong
Recruitment hospital [5] 0 0
Research Site - Melbourne
Recruitment hospital [6] 0 0
Research Site - Perth
Recruitment hospital [7] 0 0
Research Site - Sydney
Recruitment hospital [8] 0 0
Research Site - Tasmania
Recruitment postcode(s) [1] 0 0
- Adelaide
Recruitment postcode(s) [2] 0 0
- Brisbane
Recruitment postcode(s) [3] 0 0
- Cairns
Recruitment postcode(s) [4] 0 0
- Geelong
Recruitment postcode(s) [5] 0 0
- Melbourne
Recruitment postcode(s) [6] 0 0
- Perth
Recruitment postcode(s) [7] 0 0
- Sydney
Recruitment postcode(s) [8] 0 0
- Tasmania
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arkansas
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Hawaii
Country [8] 0 0
United States of America
State/province [8] 0 0
Idaho
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Kansas
Country [11] 0 0
United States of America
State/province [11] 0 0
Louisiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Maryland
Country [13] 0 0
United States of America
State/province [13] 0 0
Michigan
Country [14] 0 0
United States of America
State/province [14] 0 0
Nevada
Country [15] 0 0
United States of America
State/province [15] 0 0
New Jersey
Country [16] 0 0
United States of America
State/province [16] 0 0
New Mexico
Country [17] 0 0
United States of America
State/province [17] 0 0
New York
Country [18] 0 0
United States of America
State/province [18] 0 0
North Carolina
Country [19] 0 0
United States of America
State/province [19] 0 0
Ohio
Country [20] 0 0
United States of America
State/province [20] 0 0
Oklahoma
Country [21] 0 0
United States of America
State/province [21] 0 0
Oregon
Country [22] 0 0
United States of America
State/province [22] 0 0
Pennsylvania
Country [23] 0 0
United States of America
State/province [23] 0 0
South Carolina
Country [24] 0 0
United States of America
State/province [24] 0 0
Tennessee
Country [25] 0 0
United States of America
State/province [25] 0 0
Texas
Country [26] 0 0
United States of America
State/province [26] 0 0
Virginia
Country [27] 0 0
United States of America
State/province [27] 0 0
Washington
Country [28] 0 0
United States of America
State/province [28] 0 0
Wisconsin
Country [29] 0 0
Argentina
State/province [29] 0 0
Buenos Aires
Country [30] 0 0
Argentina
State/province [30] 0 0
Ciudad de Buenos Aires
Country [31] 0 0
Argentina
State/province [31] 0 0
Córdoba
Country [32] 0 0
Argentina
State/province [32] 0 0
Rosario
Country [33] 0 0
Argentina
State/province [33] 0 0
Salta - Salta
Country [34] 0 0
Brazil
State/province [34] 0 0
Curitiba
Country [35] 0 0
Brazil
State/province [35] 0 0
Fortaleza
Country [36] 0 0
Brazil
State/province [36] 0 0
Goiânia
Country [37] 0 0
Brazil
State/province [37] 0 0
Porto Alegre
Country [38] 0 0
Brazil
State/province [38] 0 0
Ribeirão Preto
Country [39] 0 0
Brazil
State/province [39] 0 0
São Paulo
Country [40] 0 0
Canada
State/province [40] 0 0
Alberta
Country [41] 0 0
Canada
State/province [41] 0 0
British Columbia
Country [42] 0 0
Canada
State/province [42] 0 0
Manitoba
Country [43] 0 0
Canada
State/province [43] 0 0
Newfoundland and Labrador
Country [44] 0 0
Canada
State/province [44] 0 0
Ontario
Country [45] 0 0
Canada
State/province [45] 0 0
Quebec
Country [46] 0 0
Czech Republic
State/province [46] 0 0
Brno
Country [47] 0 0
Czech Republic
State/province [47] 0 0
Hodonin
Country [48] 0 0
Czech Republic
State/province [48] 0 0
Hradec Kralove
Country [49] 0 0
Czech Republic
State/province [49] 0 0
Plzen
Country [50] 0 0
Czech Republic
State/province [50] 0 0
Praha 5
Country [51] 0 0
Czech Republic
State/province [51] 0 0
Pribram
Country [52] 0 0
Czech Republic
State/province [52] 0 0
Semily
Country [53] 0 0
Czech Republic
State/province [53] 0 0
Tabor
Country [54] 0 0
Czech Republic
State/province [54] 0 0
Usti nad Labem
Country [55] 0 0
Estonia
State/province [55] 0 0
Paide
Country [56] 0 0
Estonia
State/province [56] 0 0
Pärnu
Country [57] 0 0
Estonia
State/province [57] 0 0
Tallinn
Country [58] 0 0
Estonia
State/province [58] 0 0
Tartu
Country [59] 0 0
Estonia
State/province [59] 0 0
Viljandi
Country [60] 0 0
Finland
State/province [60] 0 0
Helsinki
Country [61] 0 0
Finland
State/province [61] 0 0
Hämeenlinna
Country [62] 0 0
Finland
State/province [62] 0 0
Imatra
Country [63] 0 0
Finland
State/province [63] 0 0
Joensuu
Country [64] 0 0
Finland
State/province [64] 0 0
Kokkola
Country [65] 0 0
Finland
State/province [65] 0 0
Kouvola
Country [66] 0 0
Finland
State/province [66] 0 0
Kuopio
Country [67] 0 0
Finland
State/province [67] 0 0
Lahti
Country [68] 0 0
Finland
State/province [68] 0 0
Mikkeli
Country [69] 0 0
Finland
State/province [69] 0 0
Oulu
Country [70] 0 0
Finland
State/province [70] 0 0
Pietarsaari
Country [71] 0 0
Finland
State/province [71] 0 0
Salo
Country [72] 0 0
Finland
State/province [72] 0 0
Seinajoki
Country [73] 0 0
Finland
State/province [73] 0 0
Tampere
Country [74] 0 0
Finland
State/province [74] 0 0
Turku
Country [75] 0 0
Finland
State/province [75] 0 0
Vaasa
Country [76] 0 0
Finland
State/province [76] 0 0
Vantaa
Country [77] 0 0
Former Serbia and Montenegro
State/province [77] 0 0
Belgrade
Country [78] 0 0
Greece
State/province [78] 0 0
Athens
Country [79] 0 0
Greece
State/province [79] 0 0
Piraeus
Country [80] 0 0
Hong Kong
State/province [80] 0 0
Hong Kong
Country [81] 0 0
Hungary
State/province [81] 0 0
Balatonfüred
Country [82] 0 0
Hungary
State/province [82] 0 0
Budapest
Country [83] 0 0
Hungary
State/province [83] 0 0
Gyor
Country [84] 0 0
Hungary
State/province [84] 0 0
Kaposvár
Country [85] 0 0
Hungary
State/province [85] 0 0
Kecskemét
Country [86] 0 0
Hungary
State/province [86] 0 0
Miskolc
Country [87] 0 0
Hungary
State/province [87] 0 0
Siófok
Country [88] 0 0
Hungary
State/province [88] 0 0
Székesfehérvár
Country [89] 0 0
India
State/province [89] 0 0
Bangalore
Country [90] 0 0
India
State/province [90] 0 0
Hyderabad
Country [91] 0 0
India
State/province [91] 0 0
Mumbai
Country [92] 0 0
India
State/province [92] 0 0
New Delhi
Country [93] 0 0
Indonesia
State/province [93] 0 0
Jakarta
Country [94] 0 0
Indonesia
State/province [94] 0 0
Malang
Country [95] 0 0
Israel
State/province [95] 0 0
Ashkelon
Country [96] 0 0
Israel
State/province [96] 0 0
Haifa
Country [97] 0 0
Israel
State/province [97] 0 0
Holon
Country [98] 0 0
Israel
State/province [98] 0 0
Jerusalem
Country [99] 0 0
Israel
State/province [99] 0 0
Rishon-Lezion
Country [100] 0 0
Israel
State/province [100] 0 0
Tel Aviv
Country [101] 0 0
Israel
State/province [101] 0 0
Tel Hashomer
Country [102] 0 0
Israel
State/province [102] 0 0
Zefat
Country [103] 0 0
Italy
State/province [103] 0 0
Arenzano
Country [104] 0 0
Italy
State/province [104] 0 0
Chiavari (GE)
Country [105] 0 0
Italy
State/province [105] 0 0
Chieri
Country [106] 0 0
Italy
State/province [106] 0 0
Firenze
Country [107] 0 0
Italy
State/province [107] 0 0
Messina
Country [108] 0 0
Italy
State/province [108] 0 0
Milano
Country [109] 0 0
Italy
State/province [109] 0 0
Monteccio Emilia
Country [110] 0 0
Italy
State/province [110] 0 0
Napoli
Country [111] 0 0
Italy
State/province [111] 0 0
Padova
Country [112] 0 0
Italy
State/province [112] 0 0
Pescara
Country [113] 0 0
Italy
State/province [113] 0 0
Piacenza
Country [114] 0 0
Italy
State/province [114] 0 0
Pistoia
Country [115] 0 0
Italy
State/province [115] 0 0
Reggio Calabria
Country [116] 0 0
Italy
State/province [116] 0 0
Reggio Emilia
Country [117] 0 0
Italy
State/province [117] 0 0
Roma
Country [118] 0 0
Italy
State/province [118] 0 0
Scandiano
Country [119] 0 0
Italy
State/province [119] 0 0
Udine
Country [120] 0 0
Korea, Republic of
State/province [120] 0 0
Seoul
Country [121] 0 0
Korea, Republic of
State/province [121] 0 0
Suwon
Country [122] 0 0
Latvia
State/province [122] 0 0
Daugavpils
Country [123] 0 0
Latvia
State/province [123] 0 0
Jekabpils
Country [124] 0 0
Latvia
State/province [124] 0 0
Madona
Country [125] 0 0
Latvia
State/province [125] 0 0
Riga
Country [126] 0 0
Latvia
State/province [126] 0 0
SIgulda
Country [127] 0 0
Latvia
State/province [127] 0 0
Talsi
Country [128] 0 0
Latvia
State/province [128] 0 0
Valmiera
Country [129] 0 0
Lithuania
State/province [129] 0 0
Vilnius
Country [130] 0 0
Malaysia
State/province [130] 0 0
Kota Bharu
Country [131] 0 0
Malaysia
State/province [131] 0 0
Kuala Lumpur
Country [132] 0 0
Malaysia
State/province [132] 0 0
Penang
Country [133] 0 0
Netherlands
State/province [133] 0 0
Beek en Donk
Country [134] 0 0
Netherlands
State/province [134] 0 0
Bennebroek
Country [135] 0 0
Netherlands
State/province [135] 0 0
Den Haag
Country [136] 0 0
Netherlands
State/province [136] 0 0
Deurne
Country [137] 0 0
Netherlands
State/province [137] 0 0
Huizen
Country [138] 0 0
Netherlands
State/province [138] 0 0
Losser
Country [139] 0 0
Netherlands
State/province [139] 0 0
Nijverdal
Country [140] 0 0
Netherlands
State/province [140] 0 0
Rijswijk
Country [141] 0 0
Netherlands
State/province [141] 0 0
Roelofarendsveen
Country [142] 0 0
Netherlands
State/province [142] 0 0
Rotterdam
Country [143] 0 0
Philippines
State/province [143] 0 0
Cebu City
Country [144] 0 0
Philippines
State/province [144] 0 0
Makati
Country [145] 0 0
Philippines
State/province [145] 0 0
Manila
Country [146] 0 0
Philippines
State/province [146] 0 0
Marikina City
Country [147] 0 0
Philippines
State/province [147] 0 0
Pasig City
Country [148] 0 0
Philippines
State/province [148] 0 0
Quezon City
Country [149] 0 0
Poland
State/province [149] 0 0
Ochojec
Country [150] 0 0
Poland
State/province [150] 0 0
Bialystok
Country [151] 0 0
Poland
State/province [151] 0 0
Bydgoszcz
Country [152] 0 0
Poland
State/province [152] 0 0
Gdansk
Country [153] 0 0
Poland
State/province [153] 0 0
Krakow
Country [154] 0 0
Poland
State/province [154] 0 0
Lodz
Country [155] 0 0
Poland
State/province [155] 0 0
Olsztyn
Country [156] 0 0
Poland
State/province [156] 0 0
Poznan
Country [157] 0 0
Poland
State/province [157] 0 0
Radom
Country [158] 0 0
Poland
State/province [158] 0 0
Rzeszow
Country [159] 0 0
Poland
State/province [159] 0 0
Sopot
Country [160] 0 0
Poland
State/province [160] 0 0
Szczecin
Country [161] 0 0
Poland
State/province [161] 0 0
Toruñ
Country [162] 0 0
Poland
State/province [162] 0 0
Tychy
Country [163] 0 0
Poland
State/province [163] 0 0
Warszawa
Country [164] 0 0
Poland
State/province [164] 0 0
Wroclaw
Country [165] 0 0
Poland
State/province [165] 0 0
Zielona Gora
Country [166] 0 0
Portugal
State/province [166] 0 0
Almada
Country [167] 0 0
Portugal
State/province [167] 0 0
Amadora
Country [168] 0 0
Portugal
State/province [168] 0 0
Elvas
Country [169] 0 0
Portugal
State/province [169] 0 0
Lisbon
Country [170] 0 0
Portugal
State/province [170] 0 0
Portalegre
Country [171] 0 0
Russian Federation
State/province [171] 0 0
Moscow
Country [172] 0 0
Russian Federation
State/province [172] 0 0
St. Petersburg
Country [173] 0 0
Russian Federation
State/province [173] 0 0
Yaroslavl
Country [174] 0 0
Singapore
State/province [174] 0 0
Singapore
Country [175] 0 0
Slovakia
State/province [175] 0 0
Dolny Kubin
Country [176] 0 0
Slovakia
State/province [176] 0 0
Levice
Country [177] 0 0
Slovakia
State/province [177] 0 0
Lubochna
Country [178] 0 0
Slovakia
State/province [178] 0 0
Lucenec
Country [179] 0 0
Slovakia
State/province [179] 0 0
Nove Zamky
Country [180] 0 0
Slovakia
State/province [180] 0 0
Povazska Bystrica
Country [181] 0 0
Slovakia
State/province [181] 0 0
Sahy
Country [182] 0 0
Slovakia
State/province [182] 0 0
Trencin
Country [183] 0 0
Slovakia
State/province [183] 0 0
Velky Meder
Country [184] 0 0
Slovakia
State/province [184] 0 0
Zilina
Country [185] 0 0
South Africa
State/province [185] 0 0
Cape Town
Country [186] 0 0
South Africa
State/province [186] 0 0
Chatsworth
Country [187] 0 0
South Africa
State/province [187] 0 0
Durban
Country [188] 0 0
South Africa
State/province [188] 0 0
Gauteng
Country [189] 0 0
South Africa
State/province [189] 0 0
Johannesburg
Country [190] 0 0
South Africa
State/province [190] 0 0
Pretoria
Country [191] 0 0
Switzerland
State/province [191] 0 0
Bern
Country [192] 0 0
Switzerland
State/province [192] 0 0
Ilanz
Country [193] 0 0
Switzerland
State/province [193] 0 0
Lausanne
Country [194] 0 0
Switzerland
State/province [194] 0 0
Monthey
Country [195] 0 0
Switzerland
State/province [195] 0 0
Zürich
Country [196] 0 0
United Kingdom
State/province [196] 0 0
Aberdeen
Country [197] 0 0
United Kingdom
State/province [197] 0 0
Atherstone
Country [198] 0 0
United Kingdom
State/province [198] 0 0
Ayr
Country [199] 0 0
United Kingdom
State/province [199] 0 0
Bath
Country [200] 0 0
United Kingdom
State/province [200] 0 0
Belfast
Country [201] 0 0
United Kingdom
State/province [201] 0 0
Berks
Country [202] 0 0
United Kingdom
State/province [202] 0 0
Birmingham
Country [203] 0 0
United Kingdom
State/province [203] 0 0
Bolton
Country [204] 0 0
United Kingdom
State/province [204] 0 0
Bucks
Country [205] 0 0
United Kingdom
State/province [205] 0 0
Cardiff
Country [206] 0 0
United Kingdom
State/province [206] 0 0
Coventry
Country [207] 0 0
United Kingdom
State/province [207] 0 0
Dundee
Country [208] 0 0
United Kingdom
State/province [208] 0 0
Edinburgh
Country [209] 0 0
United Kingdom
State/province [209] 0 0
Glasgow
Country [210] 0 0
United Kingdom
State/province [210] 0 0
Leeds
Country [211] 0 0
United Kingdom
State/province [211] 0 0
Liverpool
Country [212] 0 0
United Kingdom
State/province [212] 0 0
Manchester
Country [213] 0 0
United Kingdom
State/province [213] 0 0
Northampton
Country [214] 0 0
United Kingdom
State/province [214] 0 0
Plymouth
Country [215] 0 0
United Kingdom
State/province [215] 0 0
Radstock
Country [216] 0 0
United Kingdom
State/province [216] 0 0
Shrewsbury
Country [217] 0 0
United Kingdom
State/province [217] 0 0
Surrey
Country [218] 0 0
United Kingdom
State/province [218] 0 0
West Bromwich
Country [219] 0 0
United Kingdom
State/province [219] 0 0
Wiltshire
Country [220] 0 0
United Kingdom
State/province [220] 0 0
Wrexham
Country [221] 0 0
Vietnam
State/province [221] 0 0
Hanoi
Country [222] 0 0
Vietnam
State/province [222] 0 0
Ho Chi Minh

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
AstraZeneca
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
This is a 107-week open-label, multi-center long-term extension study from GALLANT studies 2/22, 5, 7, 8 and 14 to monitor the safety and tolerability of oral tesaglitazar 1 mg in patients with type 2 diabetes during up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.
Trial website
https://clinicaltrials.gov/study/NCT00252876
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
AstraZeneca Galida Medical Science Director, MD
Address 0 0
AstraZeneca
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT00252876